Kardium Inc.
Kardium is developing innovative medical devices for diagnosing and treating atrial fibrillation, aiming to improve patient outcomes worldwide. The company is in a pivotal stage with FDA approval and a commercial launch of its Globe Pulsed Field System, representing a significant advancement in heart rhythm disorder treatment.
Headquarters
Burnaby, British Columbia, Canada
Company Size
51-200 employees
Founded
2007
Kardium Inc. is a Canadian medtech company focused on improving treatment for atrial fibrillation (AF). The company developed the Globe® Pulsed Field System, an all-in-one catheter solution that combines high-density mapping and precise pulsed field ablation, featuring 122 individually selectable electrodes to enable patient-specific therapy. Headquartered in Burnaby, BC, Kardium serves electrophysiologists and healthcare professionals globally with the goal of improving outcomes for patients affected by AF.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Kardium Inc..
Senior Advisor - Heart Failure Research
Eli Lilly and Company
Af Solutions Clinical Specialist Ii Columbus Ga Georgia Us Ga United States N A
bostonscientific
Af Solutions Territory Manager Michigan Detroit Us Mi United States Us Mi Grand Rapids Us Mi Lansing
bostonscientific
Territory Manager, Rhythm Solutions
bostonscientific
Senior Therapy Development Specialist Electrophysiology Apac Tokyo Japan China Shanghai Hong Kong Hong Kong Japan Tokyo Taiwan Taipei City
bostonscientific
Atrial Fibrillation Coordinator
Piedmont HealthCare